Publications by authors named "Perry Sawyer"

Claim this Profile
D
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection.
Mark E Flanagan, Todd A Blumenkopf, William H Brissette, Matthew F Brown, Jeffrey M Casavant, Perry S Sawyer

J Med Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The specificity of JAK3 kinase inhibitors.
Paul S Changelian, Deborah Moshinsky, Cyrille F Kuhn, Mark E Flanagan, Michael J Munchhof, Perry S Sawyer

Blood· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models.
Elizabeth Kudlacz, Bret Perry, Perry Sawyer, Maryrose Conklyn, Sandra McCurdy

Am J Transplant· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
Paul S Changelian, Mark E Flanagan, Douglas J Ball, Craig R Kent, Kelly S Magnuson, Perry S Sawyer

Science· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis